Drugs delivery device manufacturer Aptar Pharma has announced the opening of its second production site in India, with the inauguration of a new facility near Mumbai, India.
Located at Rabale, Navi Mumbai, this new facility is described by the company as “the first of its kind”, with the main production focusing on the DF30 metering valve platform for pMDIs and on spray pump assembly – the first in India to do so to the highest international standards using a class ISO7 clean room.
The facility will be: “Key to furthering Aptar Pharma’s commitment to provide world class quality products coupled with the outstanding responsiveness requested by our Indian customers.”
“With the launch of the second Aptar Pharma manufacturing site in Asia, after Suzhou in China, we are on track to meet our main objective of better serving Indian customers by providing locally manufactured devices”, said Marc Prieur, president Aptar Pharma Asia.
“This state-of-the-art manufacturing site, along with a highly skilled local team, shows Aptar Pharma’s strong commitment to the Indian pharmaceutical industry”.
Claiming a market leading position in Asia, including India, Aptar Pharma will become a key local employer and will continue to expand its activity, leveraging an in-depth network of local partners to forge strong links with a wide range of local players, including those in research, industry, academia and regulatory bodies.
Creating innovative drug delivery systems to meet the evolving needs of biotechnology, healthcare and pharmaceutical companies around the world, Aptar Pharma is part of US-headquartered Aptargroup, along with Aptar Beauty + Home and Aptar Food + Beverage.
The new Aptar Pharma site near Mumbai, India
